[BMJ] Abatacept is second to rituximab at risk of HBsAg reverse seroconversion in patients with rheumatic disease |
Reward10points
Best Answer
2024-4-24
|
| |
post
reply
points
20
10
Complications of femoral versus radial access in neuroendovascular procedures with propensity adjustment
10
Postprandial symptoms in disorders of gut-brain interaction and their potential as a treatment target
10
Diagnostic yield from symptomatic gastroscopy in the UK: British Society of Gastroenterology analysis using data from the National Endoscopy Database
